Cargando…
Not all patients with AML over 60 years of age should be offered early allogeneic stem cell transplantation
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905709/ https://www.ncbi.nlm.nih.gov/pubmed/34607346 http://dx.doi.org/10.1182/bloodadvances.2021004799 |
| _version_ | 1784665249291436032 |
|---|---|
| author | Deeg, H. Joachim |
| author_facet | Deeg, H. Joachim |
| author_sort | Deeg, H. Joachim |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8905709 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89057092022-03-09 Not all patients with AML over 60 years of age should be offered early allogeneic stem cell transplantation Deeg, H. Joachim Blood Adv Counterpoint American Society of Hematology 2022-03-08 /pmc/articles/PMC8905709/ /pubmed/34607346 http://dx.doi.org/10.1182/bloodadvances.2021004799 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. |
| spellingShingle | Counterpoint Deeg, H. Joachim Not all patients with AML over 60 years of age should be offered early allogeneic stem cell transplantation |
| title | Not all patients with AML over 60 years of age should be offered early allogeneic stem cell transplantation |
| title_full | Not all patients with AML over 60 years of age should be offered early allogeneic stem cell transplantation |
| title_fullStr | Not all patients with AML over 60 years of age should be offered early allogeneic stem cell transplantation |
| title_full_unstemmed | Not all patients with AML over 60 years of age should be offered early allogeneic stem cell transplantation |
| title_short | Not all patients with AML over 60 years of age should be offered early allogeneic stem cell transplantation |
| title_sort | not all patients with aml over 60 years of age should be offered early allogeneic stem cell transplantation |
| topic | Counterpoint |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905709/ https://www.ncbi.nlm.nih.gov/pubmed/34607346 http://dx.doi.org/10.1182/bloodadvances.2021004799 |
| work_keys_str_mv | AT deeghjoachim notallpatientswithamlover60yearsofageshouldbeofferedearlyallogeneicstemcelltransplantation |